Once-a-Day Beta Agonist Works in COPD, Clinical Research Study Finds
MedPageToday -- VANCOUVER -- A novel once-daily beta-2 agonist appears as effective against chronic obstructive pulmonary disease as once-daily anticholinergic treatment, researchers found.